Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aligos Therapeutics Inc (ALGS)

Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ALGS : 39.84 (+3.89%)
Aligos Therapeutics to Present at Investor Conferences in December

ALGS : 39.84 (+3.89%)
Aligos Therapeutics Reports Positive Clinical Data for ALG-000184 and ALG-055009 at AASLD 2024 Meeting

Aligos Therapeutics reported positive clinical data on ALG-000184 for hepatitis B and ALG-055009 for liver fat reduction.Quiver AI SummaryAligos Therapeutics, Inc. announced positive results from its presentations...

ALGS : 39.84 (+3.89%)
Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024

ALGS : 39.84 (+3.89%)
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

ALGS : 39.84 (+3.89%)
Aligos Therapeutics to Announce 3rd Quarter 2024 Financial Results on November 6, 2024

ALGS : 39.84 (+3.89%)
Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184

ALGS : 39.84 (+3.89%)
Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 2024

ALGS : 39.84 (+3.89%)
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ALGS : 39.84 (+3.89%)
Stocks Set to Open Higher as Investors Await Powell Speech, Debt Ceiling Optimism Lifts Sentiment

June S&P 500 futures (ESM23) are up +0.39%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.32% this morning as market participants awaited an update on plans to raise the U.S. debt ceiling while...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
LNC : 31.00 (+0.98%)
PACW : 7.54 (-2.71%)
FSLR : 182.39 (+3.70%)
CS.P.DX : 33.550 (-0.62%)
NGMS : 29.45 (+0.07%)
MMP : 69.00 (+0.67%)
OKE : 100.08 (+2.48%)
ALGS : 39.84 (+3.89%)
DD : 77.28 (+0.56%)
ALB : 88.65 (-0.30%)

Barchart Exclusives

How To Profit From The Latest Corporate Spinoffs: A Guide For Investors In 2025
How to navigate corporate spinoffs. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar